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Recently, Medknow has been acquired by Wolters Kluwer, 
a leading global information provider. It means a new 
opportunity for global exposure and impact for our 
journal. Wolters Kluwer is known throughout the world 
as the authoritative source of current, highly regarded 
information and research tools. Wolters Kluwer and its 
brands Ovid and Lippincott Williams and Wilkins are 
committed to sourcing the locally-written content and 
using Open Access models to support its discoverability 
worldwide.
INCREASING COST
Due to increasing publishing cost and other financial 
constraints in the year 2011, articles clearing in the peer 
review process or upon acceptance and articles accepted 
for the year 2012 issues, the authors are required to pay 
a minimum of Rs. 2500/- (Indian authors) and USD 150/- 
(Foreign authors) towards pre-press charges to Medknow 
Publications and Media Pvt. Ltd, Mumbai (this cost is for a 
standard length article, i.e., 1–6 pages and 2 figures, articles 
over this limit will incur higher charges).
SOURCES OF FUNDING
Most of the authors have no idea how JYP is financed 
and tend to assume that there is plenty of money with 
us. Hence, I would like to highlight in this editorial about 
the policy, which includes a clear explanation of how 
JYP is being financed and why the APCs are vital for 
the journal’s survival, APC is a need of hour. Currently, 
Journal Young Pharm. absorbs the cost of publishing only via 
print subscriptions, although there were not a reasonable 
number of subscribers to cover the publishing cost 
without charging authors. For the past 3 years, we have 
been requesting and promoting the print subscriptions in 
pharmacy colleges worldwide. However, it does not work 
every time, as most of our content is being published as 
Open Access. Most of libraries prefer to access it online.
Publishing high quality research in pharmaceutical sciences 
in the year beginning 2009, Journal of  Young Pharmacists 
(JYP) is one is one of the most preferred publications in 
the field of pharmacy within India.  (JYP) has considerably 
risen to one of the quality journals in a short span of time 
along with a high indexing status. JYP is now indexed in 
Caspur, Chemical Abstracts, DOAJ, EBSCO Publishing’s 
Electronic Databases, Expanded Academic ASAP, 
GenamicsJournalSeek, Global Health, Google Scholar, 
Health and Wellness Research Center, Health Reference 
Center Academic, Hinari, Index Copernicus, Indian Science 
Abstracts, OpenJGate, PrimoCentral, ProQuest, PubMed, 
Pubmed Central, Scimago Journal Ranking, SCOLOAR, 
SCOPUS, SIIC databases, Summon by Serial Solutions, 
and Ulrich’s International Periodical Directory. We are 
also working to get ourself listed with the science citation 
index soon.
JYP is one of the first journals started by InPharm 
Association, and currently InPharm Association publishes 
many other journals such as Systematic Reviews in Pharmacy 
(www.sysrevpharm.org), Pharmaceutical Methods (www.
phmethods.org), Journal of  Pharmaceutical Investigation 
(www.jpionline.org), and Journal of  Pharmacology and 
Pharmacotherapeutics (www.jpharmacol.com).[1-7]
JYP PUBLISHING POLICY
Journal of  Young Pharmacists’ open access policy changes 
the way in which articles are published. First,  articles 
become freely accessible.  Second, the full text is universally 
accessible online, and so an author’s work can be read 
by anyone at no cost. Third, a separate copy of the full 
text of each open access article is archived in an online 
repository from the journal. JYP articles are archived in 
PubMed Central, the US National Library of Medicine’s 
full-text repository of life science literature, DOAJ, other 
open repositories, etc. JYP articles are available in various 
publishing formats to suit individual needs.
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WHY DO WE CHARGE?
As JYP is an Open Access journal, the content is fully free 
to read. The journal is noncommercial and currently, it is 
self-financing and not supported by any major organization. 
Cost is being absorbed only with subscriptions. Hence, a 
nominal cost will be levied to cover the huge publishing cost.
Charges include
•  Journal hosting systems [Medknow Publications and 
Media Pvt. Ltd., Mumbai]
•  Manuscript submission systems [Journalonweb.com]
•  In-house copyediting and linguistic support
•  Pagination and typesetting
•  Inclusion in Crossref, giving a permanent DOI, and 
enabling easy citation in other journals.
•  Archiving in Pubmed, an internationally recognized, 
open access repository.
APCs will allow continued open access to all of JYP articles. 
The authors are asked to pay only if their article is accepted 
for publication. Waiver requests will be considered on some 
instances, by the Editor-in-Chief. The authors can become 
a ‘member’ of Inpharm Association, whereby the members 
can avail 50% discount on APCs. No charge is being made 
for articles that are rejected after the peer review. Many 
funding agencies have also realized the importance of open 
access publishing and allot specific amounts exclusively 
for such APCs.
We have included and made clear the information about 
APCs is in the Instructions to Authors and in the submission 
site [http://www.journalonweb.com/jyp]. We are taking 
care to inform the authors well in advance about the 
charges upon acceptance either before submission or after 
submission of an article. An automated acknowledgement 
letter will also have complete details about the APCs.
When a receipt of a new manuscript is confirmed by the 
journal, the authors will be reminded about the APCs. The 
authors will be informed clearly at this time that if they do 
not provide assurance that they will pay the APCs, once 
the manuscript is accepted, then the manuscript cannot be 
reviewed and the editorial office will wait until they receive 
this assurance from the author before they begin the review 
process. Else, the authors can withdraw the manuscript at 
that time. This way, the journal will not waste its time and 
resources on the review and editing process.
MISINTERPRETATION AND LIMITATIONS
Article processing charges for a journal are always assumed 
that anything could be published when it is a paid journal. 
The authors should not have any misinterpretation about 
the quality of articles being published. None of the editors 
and reviewers receives any sort of financial benefits 
although they work extensively in spare time for the growth 
of journal. I ensure there would be a worthy and quality 
publication with J Young Pharm.
Wish you a happy reading of the current issue. 
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